Literature DB >> 8021234

A polymorphism (G-->A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency.

E Angotti1, E Mele, F Costanzo, E V Avvedimento.   

Abstract

AG-->A transition at -78 base pairs from the transcription start site of the apolipoprotein A-I (apoA-I) gene has been associated with increased apoA-I serum levels in humans. We report here that this mutation (G-->A) increases significantly (5-7-fold) the expression of a reporter gene fused to the apoA-I promoter in human liver and intestine cells. In addition, the presence of A at -78 base pairs from the transcription start site of the gene significantly decreases the binding affinity of a nuclear factor present in liver and intestine cells. We suggest that the reduced affinity of this factor increases the transcription efficiency of the promoter and explains why individuals carrying the A allele have high serum apoA-I levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021234

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Transcriptional regulation of the human UDP-GlcNAc:alpha-6-D-mannoside beta-1-2-N-acetylglucosaminyltransferase II gene (MGAT2) which controls complex N-glycan synthesis.

Authors:  S H Chen; S Zhou; J Tan; H Schachter
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

2.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

3.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 4.  Human gene mutation in pathology and evolution.

Authors:  D N Cooper
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

5.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

6.  Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.

Authors:  Manjusha Dixit; Gourdas Choudhuri; Rajan Saxena; Balraj Mittal
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

7.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

8.  Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?

Authors:  C Ma; Y Zhang; X Li; J Zhang; K Chen; Y Liang; Y Chen; Z Liu; Z Zhang
Journal:  Eur J Neurol       Date:  2016-06-04       Impact factor: 6.089

9.  Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.

Authors:  Christine R Swanson; Katherine Li; Travis L Unger; Michael D Gallagher; Vivianna M Van Deerlin; Pinky Agarwal; James Leverenz; John Roberts; Ali Samii; Rachel Goldmann Gross; Howard Hurtig; Jacqueline Rick; Daniel Weintraub; John Q Trojanowski; Cyrus Zabetian; Alice S Chen-Plotkin
Journal:  Mov Disord       Date:  2014-09-16       Impact factor: 10.338

10.  Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population.

Authors:  Suzanne A Al-Bustan; Ahmad E Al-Serri; Babitha G Annice; Majed A Alnaqeeb; Ghada A Ebrahim
Journal:  BMC Med Genet       Date:  2013-09-12       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.